Pluri (PLUR) Exchange Rate Effect (2021 - 2025)
Pluri (PLUR) reported Exchange Rate Effect of -$39000.0 for Q4 2025, down 168.42% year-over-year from $57000.0 in Q4 2024, and down 77.27% quarter-over-quarter from -$22000.0 in Q3 2025.
Pluri (PLUR) Exchange Rate Effect (2021 - 2025) Analysis & Trends
Pluri (PLUR) has 5 years of Exchange Rate Effect data on file, last reported at -$39000.0 in Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at -$39000.0, down 168.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.2 million (down 1654.55% YoY), and the FY2025 annual result was -$1.1 million, down 9690.91% from the prior year.
- Exchange Rate Effect slipped to -$39000.0 in Q4 2025 per PLUR's latest filing, from -$22000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $4.3 million in Q2 2022 and troughed at -$2.1 million in Q1 2022.
- A 5-year average of $67789.5 and a median of -$39000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect jumped 640.28% in 2022, then plunged 1488.37% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $1.6 million in 2021, then sank by 83.01% to $277000.0 in 2022, then plunged by 79.42% to $57000.0 in 2023, then changed by 0.0% to $57000.0 in 2024, then slumped by 168.42% to -$39000.0 in 2025.
- Business Quant data shows PLUR's Exchange Rate Effect at -$39000.0 in Q4 2025, -$22000.0 in Q3 2025, and -$683000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39,000.00 |
| Dec 31, 2025 | -39,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -683,000.00 |
| Jun 30, 2025 | -683,000.00 |
| Mar 31, 2025 | -453,000.00 |
| Mar 31, 2025 | -453,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Sep 30, 2023 | -42,000.00 |